Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement

Clinical trial NCT03701295 · COMPLETED

Trial details

NCT number: NCT03701295
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL Leukemia Cutis Recurrent Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia

Start date: 2020-03-06
Primary completion: 2020-12-08
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.